Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-25-000051

Options or other derivatives

  • Chief Technical Officer acquired 361,990 shares (grant or award)
  • Chief Technical Officer returned 361,990 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LEE ANN L. Chief Technical Officer 2025-08-01 Returned to the company · Stock Option (right to buy) −180,995 0 D
LEE ANN L. Chief Technical Officer 2025-08-01 Grant or award · Stock Option (right to buy) +180,995 180,995 D
LEE ANN L. Chief Technical Officer 2025-08-01 Returned to the company · Stock Option (right to buy) −180,995 0 D
LEE ANN L. Chief Technical Officer 2025-08-01 Grant or award · Stock Option (right to buy) +180,995 180,995 D
Loading xslF345X05/wk-form4_1754441078.xml…